pentobarbital will decrease the level or effect of roflumilast ort affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration kommentar recommended; strong cytochrome P450 enzyme inducers decrease systemic exposure to roflumilast knipa may reduce the therapeutic effectivenessWe speak a lot about the importance of gut h